Research
Projects
Mycobacterial cords are a unique form of multicellular bacterial architectures with a high-degree of order. This is highly counterintuitive – a structure formed from constituents that themselves grow and divide from both ends seems an unlikely candidate to retain long-range order. We are interested in understanding the design principles that can explain this architectural stability, including the impact of the mechanical properties of the surrounding environment, which we model using mechanically-defined hydrogels. Our work shows that this generates heterogeneity of individual cells within the structure, and resilience that enables cords to better withstand external stresses as a collective and we are interested in how this might tip the balance towards infection or colonization.

Physics is at the heart of how the lung works. Only the tiniest of aerosol droplets, including those carrying mycobacteria make it all the way down to the alveoli. There, they encounter a lining fluid coated with pulmonary surfactant with unique surface-active properties without which we would not be able to breathe and specialized tissue-resident alveolar macrophages. These early “single-cell” interactions are a bottleneck in the infection cycle but are very hard to study directly in an animal (finding a site of infection is like finding a needle-in-a-haystack). We use and further develop lung-on-chip and in vitro granuloma models populated with primary human cells that recreate the biophysics and immunology of this niche and pair this with imaging to understand what might drive control or progression to disease and develop therapeutic approaches that deliver cargoes directly to the airway.

Single Mtb grow into large intracellular cords in a subset of alveolar macrophages that fail to control infection. We study how intracellular cord formation in these first-contact cells may disrupt the cytoskeleton, organelle function and intracellular trafficking, and the consequences this might have for cellular and tissue-resident immunology. We are particularly interested by the contribution of mechanobiology in driving these early host-Mtb infections. In vivo, these cellular interactions occur in the context of a highly mechanically active tissue environment. The lung-on-chip provides the capabilities to recreate these mechanics and understand the role they play in modulating host-Mtb infections.

Antibiotic treatments for mycobacterial diseases are long, involve lots of pills, and have many side effects. The shortest treatment for drug-sensitive TB is four months long, and treatment for NTM infections are routinely 12-18 months long, with only a 50% success rate. Many individuals who no longer harbour viable bacteria are considered cured, but in reality still suffer from long-term deficiencies in lung function that leave them susceptible to new infections. We use and develop tools around organ-chip and organoid models to understand how mycobacteria respond to antibiotic treatment in tissue-like environments and are particularly interested in the role of mycobacterial cords in this process.

Collaborators
Collaboration is essential in science. Much of what we do would be impossible without our global network of collaborators.



















